Thanks Sam I'm encouraged by the continued slow growth. An exclusivity determination could significantly change the dominance of Generic Lovaza. Let's hope the FDA can get-er done today.
Thanks Sam - finally starting to see a trend I've been waiting for - V capturing a larger market share of a growing, not shrinking, market. Still waiting to see any 1st A effect, but I'll take these numbers for now :>)